GENE (Genetic Technologies) FCF Yield % : -111.81 (As of Dec. 12, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Genetic Technologies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Genetic Technologies's Trailing 12-Month Free Cash Flow is $-4.19 Mil, and Market Cap is $3.71 Mil. Therefore, Genetic Technologies's FCF Yield % for today is -111.81%.

The historical rank and industry rank for Genetic Technologies's FCF Yield % or its related term are showing as below:

GENE' s FCF Yield % Range Over the Past 10 Years
Min: -288.02 Med: -31.21 Max: -8.25
Current: -111.81

During the past 13 years, the highest FCF Yield % of Genetic Technologies was -8.25%. The lowest was -288.02%. And the median was -31.21%.

GENE's FCF Yield % is ranked worse than
93.83% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.9 vs GENE: -111.81

Genetic Technologies's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Genetic Technologies FCF Yield % Historical Data

The historical data trend for Genetic Technologies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies FCF Yield % Chart

Genetic Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Yield %

Get a 7-Day Free Trial

-13.90

-8.43

-22.66

-40.91

-97.55

Genetic Technologies Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-51.84	-31.36	-60.44	-124.95	-

Competitive Comparison of Genetic Technologies's FCF Yield %

For the Diagnostics & Research subindustry, Genetic Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Technologies's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's FCF Yield % falls into.

Genetic Technologies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Genetic Technologies's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-6.449	/	6.61086
	=	-97.55%

Genetic Technologies's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.065	*	4	/	6.61086
	=	-124.95%

Genetic Technologies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Genetic Technologies FCF Yield % Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (NAS:GENE) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

0A4N:UK DU8:Germany GTG:Australia

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.